Diastolic heart failure

Rebecca Gary1, Leslie Davis

  • 1School of Nursing, Emory University, Atlanta, Georgia, USA.

Insights

Diastolic heart failure (DHF) affects up to 50% of heart failure patients, predominantly older women with hypertension or diabetes. Despite better survival than systolic heart failure, DHF significantly increases mortality risk in the elderly.

Area of Science:

  • Cardiology
  • Geriatrics
  • Public Health

Background:

  • Diastolic heart failure (DHF) is a prevalent condition, affecting 40-50% of heart failure patients.
  • DHF is increasingly recognized as a cardiogeriatric syndrome, with prevalence rising sharply with age, particularly in women over 80.
  • Older women with hypertension and diabetes are disproportionately affected by DHF.

Purpose of the Study:

  • To highlight the growing prevalence and clinical significance of DHF.
  • To underscore the limited evidence base for DHF treatment strategies.
  • To advocate for targeted research into novel interventions for DHF.

Main Methods:

  • This abstract synthesizes existing evidence and epidemiological data on DHF.
  • It reviews the demographic trends and risk factors associated with DHF.
  • It assesses the current state of clinical trial evidence for DHF therapies.

Main Results:

  • DHF prevalence increases significantly with age, reaching over 10% in individuals aged 80.
  • Patients with DHF face a mortality risk four times higher than healthy older adults.
  • The incidence of DHF is projected to rise due to an aging population and increased prevalence of risk factors like hypertension, diabetes, and obesity.

Conclusions:

  • DHF is a growing public health concern, particularly among the elderly population.
  • There is a critical need for more clinical trials to establish effective treatments for DHF.
  • Future research should focus on developing targeted interventions for DHF patients, who often experience reduced quality of life and exertional intolerance.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...